Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Slow-release liothyronine combinations versus levothyroxine monotherapy in hypothyroidism
IRCT20100922004794N13Phase 2Completed
- Sponsor
- Dorsa Pharmaceutical
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liothyronine and levothyroxine sodium in hypothyroidism (4 arms), sponsored by Dorsa Pharmaceutical. Primary endpoints: T3/T4 ratio, thyroid-stimulating hormone and 16 more. Started Feb 2022; status: completed.
02
Drugs
liothyroninelevothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20100922004794N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100922004794N13.